Varonis price target raised to $70 from $60 at Truist

Truist raised the firm’s price target on Varonis (VRNS) to $70 from $60 and keeps a Buy rating on the shares as part of a broader research note previewing Q3 earnings among Infrastructure and cybersecurity software names. The company is seeing strong traction with its SaaS transition and new logo growth and could see upside to revenue growth expectations from GenAI and the Managed Data Detection and Response offering, the analyst tells investors in a research note.